Raymond James Financial’s MapLight Therapeutics MPLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6,455
Closed -$231K – 5704
2026
Q2
$231K Buy
+6,455
New +$186K ﹤0.01% 4966

Other funds holding MPLT

Raymond James Financial's MPLT Position: Q3 2026 in Review

Raymond James Financial sold out of MapLight Therapeutics (MPLT) in Q3 2026, closing a stake of 6,455 shares — an estimated $231K sold.

Raymond James Financial first reported a position in MPLT in Q2 2026 and held it in 1 quarter. The position peaked at $231K in Q2 2026. 60 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.

  • Raymond James Financial reported no remaining MapLight Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Raymond James Financial sold 6,455 MapLight Therapeutics shares in Q3 2026, an estimated $231K.
  • Raymond James Financial first reported a position in MapLight Therapeutics in Q2 2026 and held it in 1 quarter.
  • Raymond James Financial's MapLight Therapeutics position peaked at $231K in Q2 2026.
  • 60 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.